Quantbot Technologies LP Lowers Position in The Cooper Companies, Inc. (NASDAQ:COO)

Quantbot Technologies LP decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 80.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 10,299 shares of the medical device company’s stock after selling 42,048 shares during the period. Quantbot Technologies LP’s holdings in Cooper Companies were worth $947,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. State Street Corp raised its stake in Cooper Companies by 1.2% in the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock worth $947,897,000 after buying an additional 104,521 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after acquiring an additional 573,908 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Cooper Companies by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock worth $527,476,000 after purchasing an additional 48,559 shares during the last quarter. Victory Capital Management Inc. boosted its position in Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock valued at $415,985,000 after purchasing an additional 574,899 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after purchasing an additional 194,118 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. Citigroup cut their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, BNP Paribas raised Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Trading Down 0.4 %

Shares of NASDAQ:COO opened at $83.70 on Wednesday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The stock has a market cap of $16.74 billion, a price-to-earnings ratio of 42.92, a PEG ratio of 2.25 and a beta of 1.02. The business has a 50-day moving average price of $89.80 and a 200-day moving average price of $97.72.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.